Correlation of ARHI upregulation with growth suppression and STAT3 inactivation in resveratrol-treated ovarian cancer cells
Author:
Affiliation:
1. Department of Oncology Center, First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Guangzhou 510407, Guangdong, China
2. South China University of Technology School of Medicine, Guangzhou 520006, Guangdong, China
Publisher
IOS Press
Subject
Cancer Research,Genetics,Oncology,General Medicine
Reference36 articles.
1. An international assessment of ovarian cancer incidence and mortality;Lowe;Gynecol Oncol,2013
2. Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology;Collins;Gynecol Oncol,2014
3. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy;Signorelli;Gynecol Oncol,2014
4. ICON1 collaborators. Optimal treatment of early-stage ovarian cancer;Collinson;Ann Oncol,2014
5. Progress in survival outcomes in patients with advanced ovarian cancer treated by neo-adjuvant platinum/taxane-based chemotherapy and late interval debulking surgery;Stoeckle;Ann Surg Oncol,2014
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Resveratrol in the Treatment of Gynecological Cancer: Mechanisms and Therapeutic Potential;Current Medicinal Chemistry;2024-05-03
2. Association of MIR4435-2HG Expression with TP53 Mutation, Estrogen Receptor Activity, and Poor Prognosis in Breast Cancer;Jentashapir Journal of Cellular and Molecular Biology;2023-12-19
3. Anti-cancer perspectives of resveratrol: a comprehensive review;Food and Agricultural Immunology;2023-11-08
4. Natural STAT3 inhibitors for cancer treatment: A Comprehensive Literature Review;Recent Patents on Anti-Cancer Drug Discovery;2023-08-03
5. Hypoxia, but Not Normoxia, Reduces Effects of Resveratrol on Cisplatin Treatment in A2780 Ovarian Cancer Cells: A Challenge for Resveratrol Use in Anticancer Adjuvant Cisplatin Therapy;International Journal of Molecular Sciences;2023-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3